PATRICK BUCAYU: Open Payments
NPI 1598379760 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,998 in 65 payments from 14 companies in 2025. Trend: 2023 $1,098 · 2024 $1,237 · 2025 $1,998
Food & beverage: $1,998
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $558 |
| Sumitomo Pharma America, Inc. | 12 | $294 |
| Ferring Pharmaceuticals Inc. | 7 | $269 |
| Verity Pharmaceuticals Inc. | 8 | $197 |
| ABBVIE INC. | 6 | $141 |
| Endo USA, Inc. | 6 | $133 |
| Olympus America Inc. | 6 | $129 |
| UROGEN PHARMA, INC. | 3 | $79 |
| Janssen Biotech, Inc. | 4 | $70 |
| Merck Sharp & Dohme LLC | 2 | $41 |
Products named: INTERSTIM, ADSTILADRIN, GEMTESA, BOTOX, ALTAVIVA, iTIND System, Tlando, XIAFLEX.
Industry payments across IN — which companies pay providers there.
